These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
523 related items for PubMed ID: 12511856
1. Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance. Doern GV. Otolaryngol Head Neck Surg; 2002 Dec; 127(6 Suppl):S17-23. PubMed ID: 12511856 [Abstract] [Full Text] [Related]
2. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group. J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398 [Abstract] [Full Text] [Related]
3. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group. Blondeau JM, Suter M, Borsos S. J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568 [Abstract] [Full Text] [Related]
4. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective. Sahm DF, Brown NP, Thornsberry C, Jones ME. Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467 [Abstract] [Full Text] [Related]
5. Trends in the activity of macrolide and beta-lactam antibiotics and resistance development. Alexander Project Group. Schito GC, Mannelli S, Pesce A. J Chemother; 1997 May; 9 Suppl 3():18-28. PubMed ID: 9248977 [Abstract] [Full Text] [Related]
6. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections. Appelbaum PC. Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544 [Abstract] [Full Text] [Related]
11. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005. Sahm DF, Brown NP, Draghi DC, Evangelista AT, Yee YC, Thornsberry C. Postgrad Med; 2008 Sep; 120(3 Suppl 1):8-15. PubMed ID: 18931466 [Abstract] [Full Text] [Related]
12. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. Inoue M, Kohno S, Kaku M, Yamaguchi K, Igari J, Yamanaka K. Int J Infect Dis; 2005 Jan; 9(1):27-36. PubMed ID: 15603993 [Abstract] [Full Text] [Related]
13. Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002. Mendes C, Kiffer CR, Blosser-Middleton RS, Jones ME, Karlowsky JA, Barth A, Rossi F, Andrade S, Sader HS, Thornsberry C, Sahm DF, GLOBAL Surveillance Initiative 2001-2002. Clin Microbiol Infect; 2004 Jun; 10(6):521-6. PubMed ID: 15191379 [Abstract] [Full Text] [Related]
14. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R. J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454 [Abstract] [Full Text] [Related]
17. Resistance patterns of selected respiratory tract pathogens in Poland. Skoczyńska A, Kadłubowski M, Waśko I, Fiett J, Hryniewicz W. Clin Microbiol Infect; 2007 Apr; 13(4):377-83. PubMed ID: 17359321 [Abstract] [Full Text] [Related]
18. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). Jacobs E, Dalhoff A, Korfmann G. Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763 [Abstract] [Full Text] [Related]
19. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Clin Infect Dis; 2001 May 15; 32 Suppl 2():S81-93. PubMed ID: 11320449 [Abstract] [Full Text] [Related]